Staging of pancreatic cancer based on the number of positive lymph nodes. BJS 2017; 104: 608-618.
Published: 14th February 2017
Authors: I. Tarantino, R. Warschkow, T. Hackert, B. M. Schmied, M. W. Büchler, O. Strobel et al.
The International Study Group on Pancreatic Surgery has stated that at least 12 lymph nodes should be evaluated for staging of pancreatic cancer. The aim of this population‐based study was to evaluate whether the number of positive lymph nodes refines staging.
Patients who underwent pancreatectomy for stage I–
Some 5036 patients were included, with a median of 18 (i.q.r. 15–24) lymph nodes examined. Positive lymph nodes were found in 3555 patients (70·6 per cent). The median duration of follow‐up was 15 (i.q.r. 8–28) months.
The number of positive lymph nodes in the resection specimen is a prognostic factor in patients with pancreatic cancer.Read more
You may also be interested in
Authors: R. Green, S. C. Charman, T. Palser
Notes: Variation in compliance related to outcomes
Authors: T. Maeta, T. Ebata, E. Hayashi, T. Kawahara, S. Mizuno, N. Matsumoto et al.
Notes: Poor survival despite portal vein resection
Average treatment effect of hepatic resection versus locoregional therapies for hepatocellular carcinoma.
Authors: A. Cucchetti, V. Mazzaferro, A. D. Pinna, C. Sposito, R. Golfieri, C. Serra et al.
Notes: Resection is better
Meta‐analysis of determinants of survival following treatment of recurrent hepatocellular carcinoma.
Authors: S. Erridge, P. H. Pucher, S. R. Markar, G. Malietzis, T. Athanasiou, A. Darzi et al.
Notes: No evidence for best treatment
Meta‐analysis of single‐port versus conventional laparoscopic cholecystectomy comparing body image and cosmesis. BJS 2017; 104: 1141-1159.
Authors: R. Haueter, T. Schütz, D. A. Raptis, P.‐A. Clavien, M. Zuber
Notes: Single port superior for cosmesis, body image and pain
Systematic review of the influence of chemotherapy‐associated liver injury on outcome after partial hepatectomy for colorectal liver metastases.
Authors: J. Zhao, K. M. C. van Mierlo, J. Gómez‐Ramírez, H. Kim, C. H. C. Pilgrim, P. Pessaux et al.
Notes: Increased complications in severe SD and steatohepatitis
Authors: R. Ahola, A. Siiki, K. Vasama, M. Vornanen, J. Sand, J. Laukkarinen et al.
Notes: Centralization influences long‐term survival
Systematic review of transarterial embolization for hepatocellular adenomas. BJS 2017; 104: 823-835.
Authors: B. V. van Rosmalen, R. J. S. Coelen, M. Bieze, O. M. van Delden, J. Verheij, C. H. C. Dejong et al.
Notes: Safe alternative to surgery
Meta‐analysis of adjuvant therapy following curative surgery for periampullary adenocarcinoma. BJS 2017; 104: 814-822.
Authors: A. Acharya, S. R. Markar, M. H. Sodergren, G. Malietzis, A. Darzi, T. Athanasiou et al.
Notes: No benefit
Authors: T. Ebata, T. Mizuno, Y. Yokoyama, T. Igami, G. Sugawara, M. Nagino et al.
Notes: irresectability revisited
Survival benefit of liver resection for Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma. BJS 2017; 104: 1045-1052.
Authors: H. Kim, S. W. Ahn, S. K. Hong, K. C. Yoon, H.‐S. Kim, Y. R. Choi et al.
Notes: Selected patients benefit